PHILADELPHIA, Feb. 4, 2016 /PRNewswire/ -- For additional resources pertaining to Guillain-Barré Syndrome (GBS), a rare neurological condition causing paralysis, and the Zika virus please contact the GBS|CIDP Foundation International. Physicians from the Foundation's 26-member Global Medical Advisory Board are available for consultation and interviews.
The Foundation is in regular contact with the CDC and NIH regarding their response as well as steering funding for research to examine the suspected link between the Zika virus and onset of GBS. The Foundation is also actively coordinating a collaborative effort with major pharmaceutical companies in response to a shortage of medicine in Central and South America that provides a viable treatment option for GBS patients.
The GBS|CIDP Foundation International is the preeminent global non-profit foundation assisting patients and families affected by GBS through support, education, research and advocacy. The Foundation has 35,000 members with over 160 chapters in 47 countries and 30 Centers of Excellence worldwide.
For additional information or to arrange an interview with a member of the Foundation's Global Medical Advisory Board or GBS patient, please contact:
SOURCE GBS|CIDP Foundation International